Kynurenic Acid Promotes Osteogenesis Via the Wnt/β-catenin Signaling

Overview

Journal In Vitro Cell Dev Biol Anim

Publisher Springer

Specialties Biology
Cell Biology

Date 2023 Jun 8

PMID 37291335

Authors

Jiangwei Ma

Pu Chen

Baojuan Deng

Rong Wang

Affiliations

Soon will be listed here.

Abstract

The role of kynurenic acid (KynA) in neurological and mental diseases has been widely studied. Emerging studies disclosed that KynA has a protective effect on tissues including heart, kidney, and retina. However, the role of KynA in osteoporosis has not been reported so far. To elucidate the role of KynA in age-related osteoporosis, both control and osteoporosis mice were administrated KynA for three consecutive months, and micro-computed tomography (μCT) analysis was then performed. In addition, primary bone marrow mesenchymal stem cells (BMSCs) were isolated for osteogenic differentiation induction and treated with KynA in vitro. Our data suggested that KynA administration rescued age-related bone loss in vivo, and KynA treatment promotes BMSC osteogenic differentiation in vitro. Moreover, KynA activated the Wnt/β-catenin signaling during BMSC osteogenic differentiation. Wnt inhibitor MSAB inhibited KynA-induced osteogenic differentiation. Further data demonstrated that KynA exerted its effect on BMSC osteogenic differentiation and Wnt/β-catenin signaling activation via G protein-coupled receptor 35 (GPR35). In conclusion, the protective effect of KynA on age-related osteoporosis was disclosed. Additionally, the promoting effect of KynA on osteoblastic differentiation via Wnt/β-catenin signaling was verified and the effect dependent on GPR35. These data suggest that KynA administration potentially contributes to the treatment of age-related osteoporosis.

Citing Articles

CRYAB suppresses ferroptosis and promotes osteogenic differentiation of human bone marrow stem cells via binding and stabilizing FTH1.

Tian B, Li X, Li W, Shi Z, He X, Wang S Aging (Albany NY). 2024; 16(10):8965-8979.

PMID: 38787373 PMC: 11164484. DOI: 10.18632/aging.205851.

The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis.

Ballesteros J, Rivas D, Duque G Nutrients. 2023; 15(14).

PMID: 37513550 PMC: 10383689. DOI: 10.3390/nu15143132.

References

Almeida M, Ambrogini E, Han L, Manolagas S, Jilka R . Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem. 2009; 284(40):27438-48. PMC: 2785673. DOI: 10.1074/jbc.M109.023572. View

Anaya J, Bollag W, Hamrick M, Isales C . The Role of Tryptophan Metabolites in Musculoskeletal Stem Cell Aging. Int J Mol Sci. 2020; 21(18). PMC: 7555967. DOI: 10.3390/ijms21186670. View

Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death Differ. 2016; 23(7):1128-39. PMC: 4946886. DOI: 10.1038/cdd.2015.168. View

Kim W, Shin H, Kim B, Kim H, Ryoo H . RUNX2-modifying enzymes: therapeutic targets for bone diseases. Exp Mol Med. 2020; 52(8):1178-1184. PMC: 8080656. DOI: 10.1038/s12276-020-0471-4. View

Leklem J . Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am J Clin Nutr. 1971; 24(6):659-72. DOI: 10.1093/ajcn/24.6.659. View

Ma J, Chen P, Wang R . G-protein-coupled receptor 124 promotes osteogenic differentiation of BMSCs through the Wnt/β-catenin pathway. In Vitro Cell Dev Biol Anim. 2022; 58(7):529-538. DOI: 10.1007/s11626-022-00684-9. View

Majlath Z, Torok N, Toldi J, Vecsei L . Memantine and Kynurenic Acid: Current Neuropharmacological Aspects. Curr Neuropharmacol. 2015; 14(2):200-9. PMC: 4825950. DOI: 10.2174/1570159x14666151113123221. View

Michalowska M, Znorko B, Kaminski T, Oksztulska-Kolanek E, Pawlak D . New insights into tryptophan and its metabolites in the regulation of bone metabolism. J Physiol Pharmacol. 2016; 66(6):779-91. View

Nahomi R, Nam M, Rankenberg J, Rakete S, Houck J, Johnson G . Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice. Int J Mol Sci. 2020; 21(5). PMC: 7084183. DOI: 10.3390/ijms21051795. View

10.

Parada-Turska J, Zgrajka W, Majdan M . Kynurenic acid in synovial fluid and serum of patients with rheumatoid arthritis, spondyloarthropathy, and osteoarthritis. J Rheumatol. 2013; 40(6):903-9. DOI: 10.3899/jrheum.121035. View

11.

Perkins M, Stone T . An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 1982; 247(1):184-7. DOI: 10.1016/0006-8993(82)91048-4. View

12.

Pierce J, Begun D, Westendorf J, McGee-Lawrence M . Defining osteoblast and adipocyte lineages in the bone marrow. Bone. 2018; 118:2-7. PMC: 6240509. DOI: 10.1016/j.bone.2018.05.019. View

13.

Ramos-Chavez L, Lugo Huitron R, Gonzalez Esquivel D, Pineda B, Rios C, Silva-Adaya D . Relevance of Alternative Routes of Kynurenic Acid Production in the Brain. Oxid Med Cell Longev. 2018; 2018:5272741. PMC: 5994304. DOI: 10.1155/2018/5272741. View

14.

Rejdak R, Junemann A, Grieb P, Thaler S, Schuettauf F, Choragiewicz T . Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration. Pharmacol Rep. 2012; 63(6):1324-34. DOI: 10.1016/s1734-1140(11)70697-1. View

15.

Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M . Tryptophan Metabolism and Gut-Brain Homeostasis. Int J Mol Sci. 2021; 22(6). PMC: 8000752. DOI: 10.3390/ijms22062973. View

16.

Schwarcz R, DU F, Schmidt W, Turski W, Gramsbergen J, Okuno E . Kynurenic acid: a potential pathogen in brain disorders. Ann N Y Acad Sci. 1992; 648:140-53. DOI: 10.1111/j.1749-6632.1992.tb24532.x. View

17.

Stone T, Stoy N, Darlington L . An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol Sci. 2012; 34(2):136-43. DOI: 10.1016/j.tips.2012.09.006. View

18.

Tuboly G, Tar L, Bohar Z, Safrany-Fark A, Petrovszki Z, Kekesi G . The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level. Brain Res Bull. 2015; 112:52-60. DOI: 10.1016/j.brainresbull.2015.02.001. View

19.

Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H . Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem. 2006; 281(31):22021-22028. DOI: 10.1074/jbc.M603503200. View

20.

Wei W, Wan Y . Thiazolidinediones on PPARγ: The Roles in Bone Remodeling. PPAR Res. 2011; 2011:867180. PMC: 3205770. DOI: 10.1155/2011/867180. View